These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 16312044

  • 41. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
    Rodríguez T, Méndez R, Del Campo A, Jiménez P, Aptsiauri N, Garrido F, Ruiz-Cabello F.
    BMC Cancer; 2007 Feb 23; 7():34. PubMed ID: 17319941
    [Abstract] [Full Text] [Related]

  • 42. 15-Deoxy-12,14-prostaglandin J2 inhibits interferon gamma induced MHC class II but not class I expression on ARPE cells through a PPAR gamma independent mechanism.
    Willermain F, Dulku S, Gonzalez NS, Blero D, Driessens G, De Graef C, Caspers L, Bruyns C.
    Prostaglandins Other Lipid Mediat; 2006 Sep 23; 80(3-4):136-43. PubMed ID: 16939878
    [Abstract] [Full Text] [Related]

  • 43. Regulation of the class II and class I MHC pathways in human THP-1 monocytic cells by interleukin-27.
    Feng XM, Liu N, Yang SG, Hu LY, Chen XL, Fang ZH, Ren Q, Lu SH, Liu B, Han ZC.
    Biochem Biophys Res Commun; 2008 Mar 14; 367(3):553-9. PubMed ID: 18178151
    [Abstract] [Full Text] [Related]

  • 44. Enhancement of CIITA transcriptional function by ubiquitin.
    Greer SF, Zika E, Conti B, Zhu XS, Ting JP.
    Nat Immunol; 2003 Nov 14; 4(11):1074-82. PubMed ID: 14528304
    [Abstract] [Full Text] [Related]

  • 45. Class II transactivator (CIITA) isoform expression and activity in melanoma.
    Baton F, Deruyffelaere C, Chapin M, Prod'homme T, Charron D, Al-Daccak R, Alcaide-Loridan C.
    Melanoma Res; 2004 Dec 14; 14(6):453-61. PubMed ID: 15577315
    [Abstract] [Full Text] [Related]

  • 46. Inhibition of alloresponse by a human trophoblast non-coding RNA suppressing class II transactivator promoter III and major histocompatibility class II expression in murine B-lymphocytes.
    Geirsson A, Bothwell AL, Hammond GL.
    J Heart Lung Transplant; 2004 Sep 14; 23(9):1077-81. PubMed ID: 15454174
    [Abstract] [Full Text] [Related]

  • 47. Direct role of NF-kappaB activation in Toll-like receptor-triggered HLA-DRA expression.
    Lee KW, Lee Y, Kim DS, Kwon HJ.
    Eur J Immunol; 2006 May 14; 36(5):1254-66. PubMed ID: 16619292
    [Abstract] [Full Text] [Related]

  • 48. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
    Berghuis D, de Hooge AS, Santos SJ, Horst D, Wiertz EJ, van Eggermond MC, van den Elsen PJ, Taminiau AH, Ottaviano L, Schaefer KL, Dirksen U, Hooijberg E, Mulder A, Melief CJ, Egeler RM, Schilham MW, Jordanova ES, Hogendoorn PC, Lankester AC.
    J Pathol; 2009 Jun 14; 218(2):222-31. PubMed ID: 19274709
    [Abstract] [Full Text] [Related]

  • 49. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
    Bosch JJ, Thompson JA, Srivastava MK, Iheagwara UK, Murray TG, Lotem M, Ksander BR, Ostrand-Rosenberg S.
    Cancer Res; 2007 May 01; 67(9):4499-506. PubMed ID: 17483366
    [Abstract] [Full Text] [Related]

  • 50. [Cloning and biological activities of riboenzymes against major histocompatibility complex class II transactivator].
    Guo R, Zou P, Yang XC, Lu HZ, Gao F, Cao YL, Zhang M, Fan HH.
    Zhonghua Yi Xue Za Zhi; 2003 Apr 25; 83(8):669-72. PubMed ID: 12887826
    [Abstract] [Full Text] [Related]

  • 51. The N-terminal domain of NLRC5 confers transcriptional activity for MHC class I and II gene expression.
    Neerincx A, Jakobshagen K, Utermöhlen O, Büning H, Steimle V, Kufer TA.
    J Immunol; 2014 Sep 15; 193(6):3090-100. PubMed ID: 25127861
    [Abstract] [Full Text] [Related]

  • 52. Oct-1 DNA binding activity unresponsive to retinoblastoma protein expression prevents MHC class II induction in a non-small cell lung carcinoma cell line.
    Osborne AR, Zhang H, Blanck G.
    Mol Immunol; 2006 Feb 15; 43(6):710-6. PubMed ID: 16360016
    [Abstract] [Full Text] [Related]

  • 53. Invariant chain+ N2a neuroblastoma cells stably expressing the class II MHC transactivator CIITA fail to stimulate anti-tumor immunity.
    Rickard S, Ono SJ.
    Exp Mol Pathol; 2008 Dec 15; 85(3):147-54. PubMed ID: 18952077
    [Abstract] [Full Text] [Related]

  • 54. Epigenetic silencing of MHC2TA transcription in cancer.
    Holling TM, van Eggermond MC, Jager MJ, van den Elsen PJ.
    Biochem Pharmacol; 2006 Nov 30; 72(11):1570-6. PubMed ID: 16879803
    [Abstract] [Full Text] [Related]

  • 55. Epigenetic regulation of MHC-II and CIITA genes.
    Wright KL, Ting JP.
    Trends Immunol; 2006 Sep 30; 27(9):405-12. PubMed ID: 16870508
    [Abstract] [Full Text] [Related]

  • 56. Mutation in the class II trans-activator leading to a mild immunodeficiency.
    Wiszniewski W, Fondaneche MC, Le Deist F, Kanariou M, Selz F, Brousse N, Steimle V, Barbieri G, Alcaide-Loridan C, Charron D, Fischer A, Lisowska-Grospierre B.
    J Immunol; 2001 Aug 01; 167(3):1787-94. PubMed ID: 11466404
    [Abstract] [Full Text] [Related]

  • 57. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
    Krawczyk M, Masternak K, Zufferey M, Barras E, Reith W.
    Mol Cell Biol; 2005 Oct 01; 25(19):8607-18. PubMed ID: 16166641
    [Abstract] [Full Text] [Related]

  • 58. Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease.
    Krawczyk M, Reith W.
    Tissue Antigens; 2006 Mar 01; 67(3):183-97. PubMed ID: 16573555
    [Abstract] [Full Text] [Related]

  • 59. Differential nerve injury-induced expression of MHC class II in the mouse correlates to genetic variability in the type I promoter of C2ta.
    Harnesk K, Swanberg M, Diez M, Olsson T, Piehl F, Lidman O.
    J Neuroimmunol; 2009 Jul 25; 212(1-2):44-52. PubMed ID: 19481818
    [Abstract] [Full Text] [Related]

  • 60. [Specific promoter activity of CIITA-pI in dendritic cells].
    Zhang Y, Shen Q.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jan 25; 20(1):55-7. PubMed ID: 15182622
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.